At Home Study

Learn more about the Mi-Helper device.
How it Works

Mi-Helper At Home Study 

The initial recruitment for the Mi-Helper At Home Study is complete. Mi Helper will resume recruitment in the Spring of 2024

{Mi-Helper’s neuromodulation technology has the potential to be an at-home, non-invasive therapy for the treatment of migraine. Results from their prior clinical trial suggest that neuromodulation through transnasal air flow is promising, and may provide patients with relief from associated head pain and symptoms. As a longstanding advisor for Mi-Helper, I am excited to see its impact on migraine-related outcomes
Stewart J. Tepper, MD, FAHS
Vice President
The New England Institute for Neurology and Headache, Stamford, CT